Seeing a therapeutic effect in slowing kidney cyst growth with the combined immune checkpoint blockade and an associated remodeling of adaptive immunity not only provides functional evidence that immune checkpoint activation is a pathogenic driver of PKD, but also reemphasizes the role of adaptive immune cells, specifically CD8+ T cells, in modulating PKD progression. Here, CD8A is linked to Complex Cyst of Kidney.